drugset / Trial / NCT00337116

Intravenous Isosorbide Dinitrate Versus Sublingual Isosorbide Dinitrate for the Relief of Acute Anginal Episodes in Acute Coronary Syndrome (ACS) Patients

NCT00337116

Phase 4 Withdrawn 80 enrolled Soroka University Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a randomized, double blind, placebo-controlled study, clinical trail designed to evaluate the efficacy safety and superiority of intravenous boluses of isosorbide dinitrate for the relief of acute anginal pain episodes in acute coronary syndrome patients in comparison with the usual manner of S/L isosorbide dinitrate .

Timeline

Start
2007-01
Primary completion
2007-12
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Isosorbide Dinitrate Other / unclassified Intravenous